besg_1_screening

besg_1_screening

besg_1_screening

• Path: resources/besg_1_screening/data.parquet
• Primary key: (event)

Fields in the besg_1_screening resource.

Name	Title	Type	Description
event	The unique name of the event	string	The unique name identifying the event when the form was filled in.
center	Research center	string	The research center where the data item was recorded.
date_v1	date_v1	date	Date of visit. Recorded by study staff. Visit 1.
staff_initials_v1	staff_initials_v1	string	Initials of the study staff member responsible for conducting the screening. Visit 1.
identified_name_cpr_v1	identified_name_cpr_v1	string	Whether the participant has been identified by full name and personal identification number (CPR). Recorded by study staff. Visit 1.
relative_v1	relative_v1	string	Whether a relative or accompanying person is present at the visit. Recorded by study staff. Visit 1.
relative_name_v1	relative_name_v1	string	Specifies the accompanying relative or support person present at the visit. Recorded by study staff. Visit 1.
aim_screening_v1	aim_screening_v1	string	Whether the purpose of the screening visit has been explained by the study staff. Visit 1.
consent_info_read_v1	consent_info_read_v1	string	Whether the participant has read the written information. Visit 1.
consent_info_given_v1	consent_info_given_v1	string	Whether the participant has been informed about the purpose of the study and what it involves. Visit 1.
consent_24h_reflection_v1	consent_24h_reflection_v1	string	Whether the participant has been informed of their right to a minimum of 24 hours to consider participation. Visit 1.
consent_24h_reflection_use_v1	consent_24h_reflection_use_v1	string	States if the participant wishes to use the 24-hour rule. Visit 1.
consent_24h_reflection_date_planned_participant_v1	consent_24h_reflection_date_planned_participant_v1	string	Verifies that the 24-hour reflection follow-up appointment is scheduled in the participant’s calendar. Visit 1.
consent_24h_reflection_date_planned_staff_v1	consent_24h_reflection_date_planned_staff_v1	string	Verifies that the 24-hour reflection follow-up appointment is scheduled in the staff’s calendar. Visit 1.
consent_questions_asked_v1	consent_questions_asked_v1	string	Whether the participant has been asked if there is any questions. Visit 1.
consent_time_commitment_asked_v1	consent_time_commitment_asked_v1	string	Whether the participant has been asked if the time requirement for the study is realistic. Visit 1.
consent_signed_v1	consent_signed_v1	string	Whether the participant has signed the declaration of consent. Visit 1.
staff_signed_consent_v1	staff_signed_consent_v1	string	Whether the staff member has signes the declaration of consent. Visit 1.
consent_copy_taken_v1	consent_copy_taken_v1	string	Whether there has been made a copy of the written consent. Visit 1.
consent_copy_given_v1	consent_copy_given_v1	string	Whether the participant has received a copy of the written consent. Visit 1.
consent_original_filed_v1	consent_original_filed_v1	string	Whether the written consent has been saved on the L-drev. Visit 1.
contact_other_trials_v1	contact_other_trials_v1	string	Participant’s consent to future contact regarding other research studies, recorded verbally and documented in REDCap. Recorded by study staff. Visit 1.
wants_results_v1	wants_results_v1	string	Participant’s preference regarding receiving their personal study results, recorded verbally and documented in REDCap. Recorded by study staff. Visit 1.
age_v1	age_v1	number	Age of participant. V1.
height_v1	height_v1	number	Participant’s height in meters, measured with a stadiometer to the nearest 0.1 cm. Visit 1.
weight_v1	weight_v1	number	Participant’s weight in kilograms, measured with light clothing using a digital scale. Measured to the nearest 0.1 kg. Visit 1.
bmi_v1	bmi_v1	string	Body Mass Index (BMI) in kg/m², calculated from weight and height. Visit 1. Derived using the formula: round(([weight_v1])/(([height_v1])^(2)), 1)
bmi_eligible_v1	bmi_eligible_v1	string	Indicates whether the participant meets the BMI inclusion criterion. Recorded by study staff. Visit 1.
t2d_diagnose_v1	t2d_diagnose_v1	string	Diagnosis status of type 2 diabetes. Visit 1.
t2d_duration_v1	t2d_duration_v1	string	Number of years since participant was diagnosed with type 2 diabetes. Visit 1. Derived using the formula: [stamdata_arm_1][t2d_duration_stamdata]
weight_change_v1	weight_change_v1	string	Participant’s self-reported weight stability over the past 3 months (±3 kg). Visit 1.
weight_change_3months_v1	weight_change_3months_v1	number	Participant’s self-reported weight change over the past 3 months, stated in kilograms (gain or loss). Visit 1.
insulin_use_v1	insulin_use_v1	string	Insulin treatment status within the past 6 months (any type). Visit 1.
heart_failure_v1	heart_failure_v1	string	Presence of heart failure with reduced ejection fraction (EF < 40%) and current or planned treatment with SGLT-2 inhibitors. Self-reported by participant. Visit 1.
cvd_v1	cvd_v1	string	Established CVD with prescribed GLP-1 RA and/or SGLT-2 inhibitor. Visit 1.
kidney_disease_v1	kidney_disease_v1	string	Chronic kidney disease defined as eGFR < 60 mL/min/1.73 m² and/or albuminuria ≥ 30 mg/g for ≥ 3 months, with ongoing or planned SGLT-2 inhibitor therapy. Visit 1.
physical_health_v1	physical_health_v1	string	Presence of physical health problems that prevent participation in planned physical activity during the intervention. Self-reported by the participant. Visit 1.
physical_health_example_v1	physical_health_example_v1	string	Description of physical health problems preventing participation in planned physical activity during the intervention. Self-reported by participant. Visit 1.
training_notes_v1	training_notes_v1	string	Note any relevant physical limitations or conditions that may affect exercise participation, for example back pain or osteoarthritis of the right knee. Visit 1. Added from ID11.
food_allergies_v1	food_allergies_v1	string	Presence of dietary restrictions or allergies that prevent adherence to the planned dietary intervention. Self-reported by participant. Visit 1.
food_allergies_example_v1	food_allergies_example_v1	string	Description of dietary restrictions or food allergies preventing adherence to the planned diet. Self-reported by the participant. Visit 1.
diet_notes_v1	diet_notes_v1	string	Note any relevant dietary habits or restrictions, for example if the participant generally follows a low-carbohydrate diet. Visit 1. Added from ID11.
pregnant_v1	pregnant_v1	string	Participant’s pregnancy status or plans to become pregnant within the next year. Self-reported by participant. Visit 1.
pregnancy_test_result_v1	pregnancy_test_result_v1	string	Indicates if the participant had a negative or positive pregnancy test. 1: Negative, 2: Positive. Visit 1.
alcohol_or_substance_misuse_v1	alcohol_or_substance_misuse_v1	string	Participant’s history of alcohol or substance abuse, or current treatment for alcohol dependence (including pharmacological treatment). Self-reported by participant. Visit 1.
psychiatric_disease_v1	psychiatric_disease_v1	string	Presence of psychiatric disease. Self-reported by participant. Visit 1.
psychiatric_disease_specific_v1	psychiatric_disease_specific_v1	string	Specification of psychiatric disease. Visit 1.
psychiatric_disease_medication_change_v1	psychiatric_disease_medication_change_v1	string	Any changes in psychiatric medication within the last 3 months. Visit 1.
psychiatric_disease_medication_change_specific_v1	psychiatric_disease_medication_change_specific_v1	string	Specification of changes in psychiatric medication within the last 3 months. Visit 1. Visit 1.
psychiatric_hospitalization_v1	psychiatric_hospitalization_v1	string	Whether the participant has had any acute psychiatric visits or hospital admissions within the last 6 months. Visit 1.
psychiatric_disease_barrier_v1	psychiatric_disease_barrier_v1	string	Whether the participant’s mental condition (other than those previously mentioned) is considered to prevent study participation. Assed by study staff. Visit 1.
psychiatric_disease_barrier_reason_v1	psychiatric_disease_barrier_reason_v1	string	Specify the reason why the mental condition is considered to prevent study participation. Recorded by study staff. Visit 1.
binge_eating_v1	binge_eating_v1	string	Diagnosis status of binge eating disorder. Self-reported by participant. Visit 1.
bed_q_diagnostic_score_v1	bed_q_diagnostic_score_v1	string	Whether the participant meets the criteria for BED-diagnosis. Visit 1. Derived using the formula: [besg_1__screening_arm_1][bed_q_diagnostic_score]
bed_burden_score_v1	bed_burden_score_v1	string	BED burden score. Visit 1. Derived using the formula: [besg_1__screening_arm_1][bed_q_burden_score]
other_intervention_v1	other_intervention_v1	string	Participation status or plans to participate in another intervention study (medical or lifestyle) involving alternative treatment. Self-reported by participant. Visit 1.
language_barrier_v1	language_barrier_v1	string	Participant’s difficulties in understanding Danish, both written and spoken. Self-reported by participant and assessed by study staff. Visit 1.
compliance_risk_v1	compliance_risk_v1	string	Assessment of whether the participant is unlikely to comply with study procedures and/or interventions (e.g., attendance, measurements, counselling). Assessed by study staff. Visit 1.
compliance_risk_expl_v1	compliance_risk_expl_v1	string	Notes explaining the assessment of the participant’s likelihood to comply with study procedures and/or interventions. Reported by study staff. Visit 1.
medicinelist_v1	medicinelist_v1	string	Indicates if the medicine list from FMK has been reviewed with the participant and possible changes. Visit 4.
metformin_dose_v1	metformin_dose_v1	number	States the metformin dose. Mg/day. Visit 4.
canagliflozin_dose_v1	canagliflozin_dose_v1	number	States the Canagliflozin dose. Mg/day. Visit 4.
dapagliflozin_dose_v1	dapagliflozin_dose_v1	number	States the Dapagliflozin dose. Mg/day. Visit 4.
empagliflozin_dose_v1	empagliflozin_dose_v1	number	States the Empagliflozin dose. Mg/day. Visit 4.
other_sglt2_v1	other_sglt2_v1	string	Specifies the name of the SGLT-2 inhibitor if not reported on the provided list. Visit 4.
other_sglt2_dose_v1	other_sglt2_dose_v1	number	States the dose of “other SGLT-2 inhibitor”. Mg/day. Visit 4.
sitagliptin_dose_v1	sitagliptin_dose_v1	number	States the Sitagliptin dose. Mg/day. Visit 4.
linagliptin_dose_v1	linagliptin_dose_v1	string	States the Linagliptin dose. Mg/day. Visit 4.
other_dppiv_v1	other_dppiv_v1	string	Specifies the name of the DPP-IV inhibitor if not reported on the provided list. Visit 4.
other_dppiv_dose_v1	other_dppiv_dose_v1	number	States the dose of “other DPP-IV inhibitor”. Mg/day. Visit 4.
gliclazid_dose_v1	gliclazid_dose_v1	number	States the Gliclazid dose. Mg/day. Visit 4.
glimepirid_dose_v1	glimepirid_dose_v1	number	States the Glimepirid dose. Mg/day. Visit 4.
other_sulfonyl_name_v1	other_sulfonyl_name_v1	string	Specifies the name of the sulfonylurea if not reported on the provided list. Visit 4.
other_sulfonyl_dose_v1	other_sulfonyl_dose_v1	number	States the dose of “other sulfonylurea”. Mg/day. Visit 4.
semaglutid_sc_dose_v1	semaglutid_sc_dose_v1	number	States the Semsglutid s.c. dose. Mg/week. Visit 4.
semaglutid_po_dose_v1	semaglutid_po_dose_v1	number	States the Semaglutid p.o. dose. Mg/day. Visit 4.
dulaglutid_sc_dose_v1	dulaglutid_sc_dose_v1	number	States the Dulaglutid dose. Mg/week. Visit 4.
tirzepatid_dose_v1	tirzepatid_dose_v1	number	States the Tirzepatid dose. Mg/week. Visit 4.
other_glp1ra_v1	other_glp1ra_v1	string	Specifies the name of the GLP-1 receptor agonist if not reported on the provided list. Visit 4.
other_glp1ra_dose_v1	other_glp1ra_dose_v1	number	States the dose of “other GLP-1 receptor agonist”. Mg/day or mg/week. Visit 4.
other_glp1ra_dose_unit_v1	other_glp1ra_dose_unit_v1	string	Specifies if the dose of “other GLP-1 receptor agonist” is mg/day or mg/week. Visit 4.
other_antidiabetic_v1	other_antidiabetic_v1	string	Specifies antidiabetics if not reported on the provided list. Visit 4.
other_antidiabetic_dose_v1	other_antidiabetic_dose_v1	number	States the dose of “other antidiabetics”. Mg/day. Visit 4.
bendroflumethiazid_dose_v1	bendroflumethiazid_dose_v1	number	States the Bendroflumethiazid with KCl dose. Mg/day. Visit 4.
hydrochlorthiazid_dose_v1	hydrochlorthiazid_dose_v1	number	States the Hydrochlorthiazid dose. Mg/day. Visit 4.
other_thiazid_v1	other_thiazid_v1	string	Specifies the name of the thiazide if not reported on the provided list. Visit 4.
other_thiazid_dose_v1	other_thiazid_dose_v1	number	States the dose of “other thiazide”. Mg/day. Visit 4.
amlodipin_dose_v1	amlodipin_dose_v1	number	States the Amlodipin dose. Mg/day. Visit 4.
lercanidipin_dose_v1	lercanidipin_dose_v1	number	States the Lercanidipin dose. Mg/day. Visit 4.
verapamil_dose_v1	verapamil_dose_v1	string	States the Verapamil dose. Mg/day. Visit 4.
diltiazem_dose_v1	diltiazem_dose_v1	string	States the Diltiazem dose. Mg/day. Visit 4.
other_calciumantagonist_v1	other_calciumantagonist_v1	string	Specifies the name of the calcium channel blocker if not reported on the provided list. Visit 4.
othter_calciumantagonist_dose_v1	othter_calciumantagonist_dose_v1	number	States the dose of “other calcium channel blocker”. Mg/day. Visit 4.
enalapril_dose_v1	enalapril_dose_v1	number	States the Enalapril dose. Mg/day. Visit 4.
ramipril_dose_v1	ramipril_dose_v1	number	States the Ramipril dose. Mg/day. Visit 4.
other_ace_v1	other_ace_v1	string	Specifies the name of the ACE inhibitor if not reported on the provided list. Visit 4.
other_ace_dose_v1	other_ace_dose_v1	number	States the dose of “other ACE inhibitor”. Mg/day. Visit 4.
losartan_dose_v1	losartan_dose_v1	number	States the Losartan dose. Mg/day. Visit 4.
candesartan_dose_v1	candesartan_dose_v1	number	States the Candesartan dose. Mg/day. Visit 4.
other_angiotensin_ii_v1	other_angiotensin_ii_v1	string	Specifies the name of the ARB if not reported on the provided list. Visit 4.
other_angiotensin_ii_dose_v1	other_angiotensin_ii_dose_v1	number	States the dose of “other ARB”. Mg/day. Visit 4.
other_antihypertensiva_v1	other_antihypertensiva_v1	string	Specifies antihypertensive medicine if not reported on the provided list. Visit 4.
other_antihypertensiva_dose_v1	other_antihypertensiva_dose_v1	number	States the dose of “other antihypertensive medicine”. Mg/day. Visit 4.
atorvastatin_dose_v1	atorvastatin_dose_v1	number	States the Atorvastatin dose. Mg/day. Visit 4.
simvastatin_dose_v1	simvastatin_dose_v1	number	States the Simvastatin dose. Mg/day. Visit 4.
rosuvastatin_dose_v1	rosuvastatin_dose_v1	number	States the Rosuvastatin dose. Mg/day. Visit 4.
gemfibrozil_dose_v1	gemfibrozil_dose_v1	string	States the Gemfibrozil dose. Mg/day. Visit 4.
ezetimib_dose_v1	ezetimib_dose_v1	string	States the Ezetimib dose. Mg/day. Visit 4.
other_statins_v1	other_statins_v1	string	Specifies the name of statins if not reported on the provided list. Visit 4.
other_statins_dose_v1	other_statins_dose_v1	number	States the dose of “other statins”. Mg/day. Visit 4.
other_medicine_v1	other_medicine_v1	string	Indicates if the participant takes any other medicine apart from antidiabetic and antihypertensive drugs. Visit 4.
other_medicine_name_v1	other_medicine_name_v1	string	Specifies the brand names of other medications used by the participant. Visit 4.
other_medicine_content_v1	other_medicine_content_v1	string	Specifies the generic names of other medications used by the participant. Visit 4.
other_medicine_dose_v1	other_medicine_dose_v1	string	Specifies the doses of other medications used by the participant. Visit 4.
supplements_v1	supplements_v1	string	Indicates if the participant takes any nutritional supplements e.g. vitamins or minerals. Visit 4.
supplements_name_v1	supplements_name_v1	string	States the names of nutritional supplements. Visit 4.
supplements_content_v1	supplements_content_v1	string	States the composition of nutritional supplements. Visit 4.
supplements_dose_v1	supplements_dose_v1	string	States the doses of nutritional supplements. Mg/day. Visit 4.
medicine_list_physical_v1	medicine_list_physical_v1	string	Medicin list placed in the folder with ID-number. Visit 4.
medicine_list_upload_v1	medicine_list_upload_v1	string	The reviewed medcine list incl. notes. Visit 4.
medicine_doctor_v1	medicine_doctor_v1	string	Indicates whether the medicine list needs to be reviewed by a doctor. Visit 4.
medicine_doctor_review_v1	medicine_doctor_review_v1	string	Indicates if the medicine list has been reviewed by a doctor. Visit 4.
screening_complete_v1	screening_complete_v1	string	Whether the screening instrument is completed.. Visit 1.
inclusion_criteria_met_v1	inclusion_criteria_met_v1	string	Whether the inclusion criterias were met. Visit 1.
exclusion_criteria_reviewed_v1	exclusion_criteria_reviewed_v1	string	Whether the exclusion criterias are reviewed. Visit 1.
stamdata_complete_v1	stamdata_complete_v1	string	Whether all the necessary data is registered in stamdata. Visit 1.
inclusion_v1	inclusion_v1	string	Assessment of participant eligibility for inclusion in the ON LiMiT feasibility study, based on screening. Asssed by study staff. Visit 1.
inclusion_assessment_expl_v1	inclusion_assessment_expl_v1	string	Notes explaining whether the participant can be included in the ON LiMiT feasibility study. Reported by study staff. Visit 1
blood_sample_taken_v1	blood_sample_taken_v1	string	Whether participant had a blood sample taken. Visit 1.
blood_sample_not_v1	blood_sample_not_v1	string	Reason to why the bloodsample has not been taken. Recorded by study staff. Visit 1.
comment_blood_sample_v1	comment_blood_sample_v1	string	Comments regarding the bloodsample. Recorded by study staff. Visit 1.
hba1c_value_v1	hba1c_value_v1	number	Participant’s HbA1c in mmol/mol, assessed from blood sample collected in non-fasting state. Visit 1.
gad65_value_v1	gad65_value_v1	string	Participants GAD65 assessed from blood sample collected in non-fastin state. Visit 1.
gad65_waiting_v1	gad65_waiting_v1	string	If GAD65 results are pending: Complete as much as possible during the screening visit. Schedule a follow-up phone call. Visit 1.
cpeptid_value_v1	cpeptid_value_v1	number	Participant’s C-peptid in pmol/L, assessed from blood sample collected in non-fasting state. Visit 1.
glucose_value_v1	glucose_value_v1	number	Participant’s glucose, assessed fom blood sample collected in non-fasting state. Visit 1.
ecg_performed_v1	ecg_performed_v1	string	Record wether the participant has had an ECG taken. Recorded by study staff. Visit 1.
ecg_not_v1	ecg_not_v1	string	Reason to why ECG has not been taken. Recorded by study staff. Visit 1.
egc_approved_v1	egc_approved_v1	string	Whether the ECG has been checked by a doctor. Recorded by study staff. Visit 1.
visit2_scheduled_v1	visit2_scheduled_v1	string	Indicate whether the participant’s visit appointments have been entered into their own calendar or into Liva. Visit 1.
appointments_booked_outlook_calendar_v1	appointments_booked_outlook_calendar_v1	string	Indicate whether the visit appointments for V2, V3, and V4 have been entered into the ON LiMiT calendar in Outlook. Visit 1. Added from ID15.
appointments_booked_sp_v1	appointments_booked_sp_v1	string	Indicate whether the visit appointments for V2, V3, and V4 have been booked in SP. Visit 1. Added from ID15.
sp_reminder_installed_v1	sp_reminder_installed_v1	string	Whether the participant has access to “Min SP” to view scheduled appointment times and receive reminders for study visits. Visit 1.
easy_sms_v1	easy_sms_v1	string	Whether the participant is enrolled in nemSMS for automatic reminders of study appointments. Visit 1.
research_active_sp_v1	research_active_sp_v1	string	Indicate whether the participant has been marked as research-active in SP. Visit 1. Added from ID15.
handed_out_v1	handed_out_v1	string	States if the participant has been handed the participant folder. Visit 1.
participant_folder_v1	participant_folder_v1	string	Whether the information in the participant folder has been reviewed. Participant is instructed to bring the folder to each visit. Visit 1.
participant_folder_questioins_v1	participant_folder_questioins_v1	string	Whether the participant has any questions regarding the material in the participant folder. Visit 1.
study_app_installation_v1	study_app_installation_v1	string	Whether the participant has the study app installed on their telephone. Visit 1.
study_app_not_installed_reason_v1	study_app_not_installed_reason_v1	string	Reason as to why the study app is not installed. Visit 1.
study_app_install_plan_v1	study_app_install_plan_v1	string	A plan for when the study app will be installed. Visit 1.
study_app_not_installed_plan_v1	study_app_not_installed_plan_v1	string	Agreement with the participant regarding installation of the study app. Visit 1.
study_app_instruction_v1	study_app_instruction_v1	string	Whether the participant has been instructed in using the study app and has been informed about monitoring via the study app. Visit 1.
diet_record_explained_v1	diet_record_explained_v1	string	Whether the instructions for completing the 3-day dietary registration in MyFood24 (link) have been reviewed with the participant. Visit 1.
myfood24_calendar_v1	myfood24_calendar_v1	string	Create a calendar appointment in the ON LiMiT calendar to send the link to the participant via Liva. For example: “Send MyFood24 link to ID09”. Invite the project dietitians NP and GS to the appointment. Visit 1. Added from ID11.
cgm_info_v1	cgm_info_v1	string	Whether the participant has been informed about the use of CGM. Visit 1.
cgm_v1	cgm_v1	string	Indicates whether the participant has been fitted with a CGM. Visit 1.
cgm_no_v1	cgm_no_v1	string	The reason why, if the participant didn’t get the CGM on. Visit 1.
sensorid_v1	sensorid_v1	string	The sensors ID number. Visit 1.
cgmreader_v1	cgmreader_v1	string	The number of the CGM reader. Visit 1.
gcm_envelop_given_v1	gcm_envelop_given_v1	string	Whether the participant has received a zip bag for the CGM. Visit 1.
sens_download_phone_v1	sens_download_phone_v1	string	Whether the participant has downloaded the SENS app to their phone. Visit 1.
sens_id_nr_v1	sens_id_nr_v1	string	Identification of the SENS tracker. Visit 1.
sens_turned_on_v1	sens_turned_on_v1	string	Indicates if tracker is turned on and time period for measuring registred in webapp. Visit 1.
sens_applied_v1	sens_applied_v1	string	Whether SENS device has been applied. Visit 1.
sens_notapplied_reason_v1	sens_notapplied_reason_v1	string	Reason why the SENS accelerometer was not applied. Recorded by study staff. Visit 1.
sens_application_date_v1	sens_application_date_v1	date	Date of SENS application. Visit 1.
sens_info_v1	sens_info_v1	string	Whether the participant has received information about SENS. Visit 1.
sens_patches_and_zip_given_v1	sens_patches_and_zip_given_v1	string	Indicates if participant has received zip bag with extra patches. Visit 1.
stoolkit_given_visit2_v1	stoolkit_given_visit2_v1	string	Whether participant has received information and materials for stool sample home collection prior to Visit 2. Visit 1.
info_before_mmtt_v1	info_before_mmtt_v1	string	Whether the participant has been informed about the preperations for visit 2 (MMTT). Visit 1.
comments_end_v1	comments_end_v1	string	General comments and observations recorded. Free-text notes by study staff. Visit 1.
treatment_v1___1	Livstilbehandling (f.eks. forløb hos diætist, træningsforløb eller andet)	boolean	Current treatment approach for type 2 diabetes - lifestyle changes and/or oral antidiabetic medication and/or incretin based medicin (e.g. GLP-1 receptor agonist). Visit 1.
treatment_v1___2	Oral antidiabetisk medicin	boolean	Current treatment approach for type 2 diabetes - lifestyle changes and/or oral antidiabetic medication and/or incretin based medicin (e.g. GLP-1 receptor agonist). Visit 1.
treatment_v1___3	Inkretinbaseret medicin (fx GLP-1 RA)	boolean	Current treatment approach for type 2 diabetes - lifestyle changes and/or oral antidiabetic medication and/or incretin based medicin (e.g. GLP-1 receptor agonist). Visit 1.
antidiabetics_medicine_v1___1	Metformin	boolean	Lists which antidiabetic medications the participant uses. Visit 4.
antidiabetics_medicine_v1___2	SGLT-2-hæmmer (Canagliflozin (Invokana), Dapagliflozin (Forxiga), Empagliflozin (Jardiance))	boolean	Lists which antidiabetic medications the participant uses. Visit 4.
antidiabetics_medicine_v1___3	DPP-IV-hæmmer (Sitagliptin (Januvia), Linagliptin (Trajenta))	boolean	Lists which antidiabetic medications the participant uses. Visit 4.
antidiabetics_medicine_v1___4	Sulfonylurinstof (Gliclazid, Glimepirid)	boolean	Lists which antidiabetic medications the participant uses. Visit 4.
antidiabetics_medicine_v1___5	GLP-1-receptoragonist (Semaglutid s.c. (Ozempic), Semaglutid p.o. (Rybelsus), Dulaglutid s.c. (Trulicity), Tirzepatid (Mounjaro))	boolean	Lists which antidiabetic medications the participant uses. Visit 4.
antidiabetics_medicine_v1___6	Andet præparat	boolean	Lists which antidiabetic medications the participant uses. Visit 4.
antidiabetics_medicine_v1___7	Deltager tager ikke antidiabetika	boolean	Lists which antidiabetic medications the participant uses. Visit 4.
sglt2_type_v1___1	Canagliflozin (Invokana)	boolean	Specifies which SGLT-2 inhibitor the participant uses. Visit 4.
sglt2_type_v1___2	Dapagliflozin (Forxiga)	boolean	Specifies which SGLT-2 inhibitor the participant uses. Visit 4.
sglt2_type_v1___3	Empagliflozin (Jardiance)	boolean	Specifies which SGLT-2 inhibitor the participant uses. Visit 4.
sglt2_type_v1___4	Andet	boolean	Specifies which SGLT-2 inhibitor the participant uses. Visit 4.
dppiv_type_v1___1	Sitagliptin (Januvia)	boolean	Specifies which DPP-4 inhibitor the participant uses. Visit 4.
dppiv_type_v1___2	Linagliptin (Trajenta)	boolean	Specifies which DPP-4 inhibitor the participant uses. Visit 4.
dppiv_type_v1___3	Andet	boolean	Specifies which DPP-4 inhibitor the participant uses. Visit 4.
sulfonyl_type_v1___1	Gliclazid	boolean	Specifies which sulfonylurea the participant uses. Visit 4.
sulfonyl_type_v1___2	Glimepirid	boolean	Specifies which sulfonylurea the participant uses. Visit 4.
sulfonyl_type_v1___3	Andet	boolean	Specifies which sulfonylurea the participant uses. Visit 4.
glp1ra_type_v1___1	Semaglutid s.c. (Ozempic)	boolean	Specifies which GLP-1 receptor agonist the participant uses. Visit 4.
glp1ra_type_v1___2	Semaglutid p.o. (Rybelsus)	boolean	Specifies which GLP-1 receptor agonist the participant uses. Visit 4.
glp1ra_type_v1___3	Dulaglutid s.c. (Trulicity)	boolean	Specifies which GLP-1 receptor agonist the participant uses. Visit 4.
glp1ra_type_v1___5	Tirzepatid (Mounjaro)	boolean	Specifies which GLP-1 receptor agonist the participant uses. Visit 4.
glp1ra_type_v1___4	Andet	boolean	Specifies which GLP-1 receptor agonist the participant uses. Visit 4.
antihypertensive_medicine_v1___1	Thiazid (bendroflumethiazid m. KCl, hydrochlorthiazid)	boolean	Lists which antihypertensive medications the participant uses. Visit 4.
antihypertensive_medicine_v1___2	Calciumantagonist (amlodipin, lercanidipin, verapamil, diltiazem)	boolean	Lists which antihypertensive medications the participant uses. Visit 4.
antihypertensive_medicine_v1___3	ACE-hæmmer (enalapril, ramipril)	boolean	Lists which antihypertensive medications the participant uses. Visit 4.
antihypertensive_medicine_v1___4	Angiotensin-II-receptorblokker (losartan, candesartan)	boolean	Lists which antihypertensive medications the participant uses. Visit 4.
antihypertensive_medicine_v1___5	Andet præparat	boolean	Lists which antihypertensive medications the participant uses. Visit 4.
antihypertensive_medicine_v1___6	Deltager tager ikke antihypertensiva	boolean	Lists which antihypertensive medications the participant uses. Visit 4.
thiazid_type_v1___1	Bendroflumethiazid m. KCl	boolean	Specifies which thiazide the participant uses. Visit 4.
thiazid_type_v1___2	Hydrochlorthiazid	boolean	Specifies which thiazide the participant uses. Visit 4.
thiazid_type_v1___3	Andet	boolean	Specifies which thiazide the participant uses. Visit 4.
calciumantagonist_type_v1___1	Amlodipin	boolean	Specifies which calcium channel blocker the participant uses. Visit 4.
calciumantagonist_type_v1___2	Lercanidipin	boolean	Specifies which calcium channel blocker the participant uses. Visit 4.
calciumantagonist_type_v1___3	Verapamil	boolean	Specifies which calcium channel blocker the participant uses. Visit 4.
calciumantagonist_type_v1___4	Diltiazem	boolean	Specifies which calcium channel blocker the participant uses. Visit 4.
calciumantagonist_type_v1___5	Andet	boolean	Specifies which calcium channel blocker the participant uses. Visit 4.
ace_type_v1___1	Enalapril	boolean	Specifies which ACE inhibitor the participant uses. Visit 4.
ace_type_v1___2	Ramipril	boolean	Specifies which ACE inhibitor the participant uses. Visit 4.
ace_type_v1___3	Andet	boolean	Specifies which ACE inhibitor the participant uses. Visit 4.
angiotensin_ii_type_v1___1	Losartan	boolean	Specifies which ARB the participant uses. Visit 4.
angiotensin_ii_type_v1___2	Candesartan	boolean	Specifies which ARB the participant uses. Visit 4.
angiotensin_ii_type_v1___3	Andet	boolean	Specifies which ARB the participant uses. Visit 4.
statins_medicine_v1___1	Atorvastatin	boolean	Lists which statins the participant uses. Visit 4.
statins_medicine_v1___2	Simvastatin	boolean	Lists which statins the participant uses. Visit 4.
statins_medicine_v1___3	Rosuvastatin	boolean	Lists which statins the participant uses. Visit 4.
statins_medicine_v1___5	Gemfibrozil (Lopid)	boolean	Lists which statins the participant uses. Visit 4.
statins_medicine_v1___6	Ezetimib	boolean	Lists which statins the participant uses. Visit 4.
statins_medicine_v1___4	Andet præparat	boolean	Lists which statins the participant uses. Visit 4.
statins_medicine_v1___7	Deltager tager ikke statiner	boolean	Lists which statins the participant uses. Visit 4.
hba1c_gad65_cpeptid_v1___1	GAD65-antistof er positiv	boolean	Participant’s GAD65 and/or C-peptid assessed from blood sample collected in non-fasting state. Visit 1.
hba1c_gad65_cpeptid_v1___2	C-peptid (stimuleret) < 800 pM	boolean	Participant’s GAD65 and/or C-peptid assessed from blood sample collected in non-fasting state. Visit 1.
hba1c_gad65_cpeptid_v1___3	Afventer svar på GAD65-antistof	boolean	Participant’s GAD65 and/or C-peptid assessed from blood sample collected in non-fasting state. Visit 1.